FORMULARY WATCH

FDA actions

8 high-profile FDA approvals

By Tracey Walker
The first PCSK9 inhibitor, hepatitis C treatments, and a heart failure drug, are among those therapies newly approved by FDA. Read more

Bleeding disorder drug shows positive results

By Christine Blank
After positive phase 3 trial data for its treatment for the bleeding disorder von Willebrand disease, Baxalta Inc. is awaiting FDA approval for the drug. Study details

CONTINUING EDUCATION

MTM essentials for COPD Management: Part 2

This month's CE activity is part of the CPE series, "Medication Therapy Management for the Patient with Respiratory Disease." From April 2015 through December 2015, pharmacists can earn up to 18 hours of CPE credit with 9 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to assist pharmacists in understanding strategies for improving patient outcomes related to COPD management.

To read and print the article with TEST QUESTIONS, click here.

To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the Session Code: 15DT32-KZV23.

The login to the Online CE Center is
https://web2.uconn.edu/pharmacyce/login.php.
To review you registration page to ensure the data is up to date, or to register, go
https://web2.uconn.edu/pharmacyce/program_register.php.
For a full list of courses, go to
http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

EDITOR'S PICK

Top 9 current drug shortages

By Christine Blank
FDA updated its list of drugs that are in short supply. Some of the drugs – such as Sodium Chloride 0.9% Injection Bags – have been in short supply for months, while others have become more problematic recently. The 9 you need to know about

August 5, 2015